GSK

Tolerx: Attacking the Cause of Type 1 Diabetes in People (Not Mice)

By AmyT on April 16, 2010

If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…

Read more »

IDEO on Designing for Health/Diabetes

By AmyT on April 27, 2009

IDEO is the world-renown design firm that transformed Kaiser Permanente’s modus operandi. They made the cover of BusinessWeek a few years ago.  They’ve won scores of design competitions themselves.
So needless to say, we’re delighted to have them on board for the DiabetesMine Design Challenge, open for submissions until May 1, 2009 (so get movin’!).  IDEO Senior Design Strategist John Lai is one of our judges this year, and two of our Design Challenge winners…

Read more »